In order to disclose our ESG initiatives and further advance our activities while incorporating the opinions of our stakeholders, we have published our integrated report, the "ROHTO Well-being Report," and have published detailed information about our sustainability initiatives on our "Sustainability Website."
Disclosure Policy
- We are working to systematize our sustainability efforts and refer to the guidelines for reporting.
- The ROHTO Well-being Report provides key information on our efforts to create social value and improve our medium- to long-term corporate value, our management vision, our awareness of the business environment, our strategies, and information related to the environment, society, and governance.
- Our Sustainability Website provides detailed reports on each of our sustainability activities, including ESG information and our efforts toward the SDGs, to help you understand our sustainability efforts.
Target period
Integrated Report "ROHTO Well-being Report 2025”: April 2024 to March 2025
Sustainability Website: April 2024 - Present
*Some activity information outside the target period is also included.
Scope of reporting
This site provides information on ROHTO Pharmaceutical Co., Ltd. and its consolidated subsidiaries in Japan and overseas.
If the scope of the activities or data published differs, this will be clearly stated individually.
*Due to the influence of decimal points, the totals of the aggregated data in this report may not match the individual figures.
Guideline Comparison Table
Contact Information